Notwithstanding the provisions of the first paragraph of Article D. 1221-58, the import authorisation may be issued by the Director General of the Agence nationale de sécurité du médicament et des produits de santé on the basis of a forward programme submitted by the importer. At the end of the authorisation period, the importer draws up a report on the operations carried out and the quantity imported during the period.